SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells

被引：0
|
作者：
Vougiouklakis, Theodore
Saloura, Vassiliki
Nakamura, Yusuke
Hamamoto, Ryuji
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4535
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Phosphatase deficiency causes constitutive phosphorylation of ERK1/2 in THP-1 cells
    Lu, YB
    Wahl, LM
    FASEB JOURNAL, 2006, 20 (05): : A923 - A924
  • [22] Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells
    D C Lev
    L S Kim
    V Melnikova
    M Ruiz
    H N Ananthaswamy
    J E Price
    British Journal of Cancer, 2004, 91 : 795 - 802
  • [23] Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells
    Lev, DC
    Kim, LS
    Melnikova, V
    Ruiz, M
    Ananthaswamy, HN
    Price, JE
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 795 - 802
  • [24] Protocol for preparing SUV420H1 in complex with the nucleosome containing H2A.Z and H4K20Ecx for structure determination
    Huang, Li
    Zhou, Zheng
    STAR PROTOCOLS, 2024, 5 (03):
  • [25] Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
    Munck, Joanne M.
    Berdini, Valerio
    Bevan, Luke D.
    Braithwaite, Hannah
    Buck, Ildiko M.
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James E.
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Hindley, Chris J.
    Kidane, Birikiti
    Kucia-Tran, Justyna
    Lyons, John F.
    Martins, Vanessa
    Muench, Sandra
    Murray, Chris W.
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David C.
    Rich, Sharna J.
    Richardson, Caroline J.
    Saini, Harpreet K.
    Shah, Alpesh
    Stanczuk, Lukas
    Thompson, Neil T.
    Walton, Hugh
    Wilsher, Nicola E.
    Woolford, Alison J.
    Wallis, Nicola G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [26] Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases
    Casar, Berta
    Rodriguez, Javier
    Gibor, Gilad
    Seger, Rony
    Crespo, Piero
    BIOCHEMICAL JOURNAL, 2012, 441 : 571 - 578
  • [27] Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    Taylor, A. P.
    Leon, E.
    Goldenberg, D. M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 82 - 89
  • [28] Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
    A P Taylor
    E Leon
    D M Goldenberg
    British Journal of Cancer, 2010, 103 : 82 - 89
  • [29] CFTR interacts with Hsp90 and regulates the phosphorylation of AKT and ERK1/2 in colorectal cancer cells
    Liu, Kaisheng
    Jin, Hongtao
    Guo, Yaomin
    Liu, Ying
    Wan, Yong
    Zhao, Pan
    Zhou, Zhifan
    Wang, Jianhong
    Wang, Maolin
    Zou, Chang
    Wu, Weiqing
    Cheng, Zhiqiang
    Dai, Yong
    FEBS OPEN BIO, 2019, 9 (06): : 1119 - 1127
  • [30] Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation
    Takeuchi, Ario
    Eto, Masatoshi
    Shiota, Masaki
    Tatsugami, Katsunori
    Yokomizo, Akira
    Kuroiwa, Kentaro
    Itsumi, Momoe
    Naito, Seiji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (05) : 1691 - 1696
12345